Bloustein School 2023 Healthcare Symposium

March 1, 2023

The interplay between health systems and the life sciences is a critical driver in the discovery and development of new therapies and cures. This symposium was designed to provide insight into the respective roles of health systems and the life sciences that foster the development of lifesaving and life-enhancing research and solutions. This half-day event included several panel discussions and included representatives from select health systems, pharmaceutical and life science companies, and patient advocates. The audience consisted of students, faculty, healthcare executives, industry representatives and the media. The symposium included three panels of approximately 50 minutes each followed by questions from the audience.


1:00 – 1:10 p.m. Welcome

  • Stuart Shapiro, PhD, Professor and Dean, Edward J. Bloustein School of Planning and Public Policy

1:10 – 1:35 p.m. Introductory Keynote

  • Tom Hubbard, MPP, Senior Vice President of Policy Research, NEHI-Network for Excellence in Health Innovation (Boston)

1:40-2:40 p.m. Panel 1: Conducting and Funding Research

Included will be a review of the value of publications, presentations and collaborative meetings. Examples from the recent COVID-19 experience will be illustrative. What is the value proposition for health systems to establish research initiatives? Where does the private sector fit into this model? How successful are these initiatives? What barriers exist that stymie basic research? What is the role of “development” stage research where private funding is more applicable—e.g., government’s role to create a venture-based ecosystem to fund startups that advance the basic research into technologies with practical application.

2:45 – 3:45 p.m. Panel 2: The Interplay Between External Industry and Health Systems

Discussion including clinical trials, patent relationships, and funding. Recommendations for improving the system will be encouraged. How are clinical trials conducted by health systems? What barriers exist that limit access to clinical trials? How are medical devices and clinical innovations pursued in the health system setting? What role does government play in this relationship? How are decentralized clinical trials conducted (e.g., COVID-mediated innovation) – leveraging data, artificial intelligence and machine learning for improving clinical trial design and analytics.

  • Moderator: Eduardo Schur, Partner/Principal, Commercial and R&D Lead Health Sciences & Wellness, EY Life Sciences; Senior Health Administration Fellow, Edward J. Bloustein School of Planning and Public Policy
  • Tim Sullivan, CEO, New Jersey Economic Development Authority (NJEDA)
  • Reynold Panettieri, MD, Vice Chancellor, Director of the Rutgers Institute for Translational Research and Science; on staff at RWJBarnabas Health
  • Atul Grover, MD, PhD, Executive Director, Research and Action Institute, Association of American Medical Colleges (AAMC)
  • Eric Whitman, MD, Medical Director, Oncology, Atlantic Health System
  • Stephanie Petrone, CCRA, MT, Navigate Clinical Consulting

3:50 – 4:50 p.m. Panel 3: Ethics and Equity in Research

A regulatory overview and discussion of government and industry concerns. Are changes necessary to enrich the research and outcomes? Are efforts underway to expand patient access and treatment initiatives? Is the system fair? Do opportunities exist in other healthcare settings, e.g., home health, outpatient facilities, etc.?

4:50 – 5:00 p.m. Closing Remarks

5:00 – 7:00 p.m. Networking Reception


Recent Posts

NJSPL – Advancing Perinatal Mental Health Equity in NJ

By Slawa Rokicki, Mitu Patel, Patricia Suplee, and Robyn D’Oria Perinatal mental health, which includes depression or anxiety that occurs during pregnancy or in the postpartum period, is a significant public health problem that disproportionately affects racial and...

Prof. Julia Sass Rubin: Advocate for Democracy

Original article published in TAPintoPrinceton, June 15, 2024 By Pam Hersh Princeton, NJ – Tuesday, June 4, Primary Election Day in New Jersey, was a big expletive-deleted deal for Princeton resident Julia Sass Rubin, whose name appeared nowhere on any ballot. Rubin,...

Nikpour Receives Office of Disability Services Award

Professor Fereydoun Nikpour was selected for the Office of Disability Services Faculty Honor Roll. The Faculty Honor Roll is a new initiative to recognize instructors who go above and beyond to support the work of the Office of Disability Services (ODS). ODS staff...

Heldrich Report: NJ’s Energy-Efficiency Workforce Needs

New Jersey's Energy-Efficiency Workforce Needs, Infrastructure, and Equity Assessment New Jersey Governor Phil Murphy’s Energy Master Plan and Executive Order 315 set a goal to reduce fossil fuel usage to 100% clean energy by 2035. The Executive Order also called for...

Shaul Picker Receives 2024 Mortensen-Voorhees Award

Shaul Picker is the 2024 recipient of the Mortensen-Voorhees Award for Achievement in Transportation Studies. This award is granted annually to the highest-achieving student with a concentration in transportation at the Edward J. Bloustein School of Urban Planning and...

Upcoming Events

Latest Past Events

Jersey City Alumni Mixer

Zeppelin Hall Biergarten 88 Liberty View Dr, Jersey City

Join us for an alumni mixer in #JerseyCity on Thursday, June 6th at Zeppelin Hall Biergarten. Parking for Zeppelin Hall is FREE - more information can be found here: This […]